(Q42718595)

English

Anti-fibrotic cardio protective efficacy of aminoguanidine against streptozotocin induced cardiac fibrosis and high glucose induced collagen up regulation in cardiac fibroblasts

scientific article published on 21 April 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Anti-fibrotic cardio protective efficacy of aminoguanidine against streptozotocin induced cardiac fibrosis and high glucose induced collagen up regulation in cardiac fibroblasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Gangadhara Prasadachari Vadla

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Elangovan Vellaichamy

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

21 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Chemico-biological Interactions

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

197

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

119-128

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Aging of myocardial collagen

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Effects of propofol on the expression of matric metalloproteinases in rat cardiac fibroblasts after hypoxia and reoxygenation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Role of extracellular matrix proteins in heart function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Matrix metalloproteinases as modulators of inflammation and innate immunity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Advanced glycation end-products: a review

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Collagen degradation and the response to parathyroid extract in the intact rhesus monkey

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Regulation of matrix metalloproteinases: an overview

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

High sensitivity to streptozotocin in herbivorous voles, Microtus arvalis, compared to mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Free radicals, diabetes and endothelial dysfunction.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Cerebroprotective effects of aminoguanidine in a rodent model of stroke

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.CBI.2012.04.005

Identifiers

10.1016/J.CBI.2012.04.005

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42718595&oldid=2073686466"